Methyl aminolevulinate treatment less painful for AK, BCC patients

Los Angeles - Photodynamic therapy using a derivative of 5-aminolevulinic acid hydrochloride (5-ALA) provides a significantly higher clinically efficacy and cosmetic result versus cryotherapy for treatment of actinic keratosis, according to Paul S. Yamauchi, M.D., Ph.D.

Related Videos
Related Content

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

New Advancements in Surgical Scar Revision

March 19th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

New Advancements in Surgical Scar Revision

March 19th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

New Advancements in Surgical Scar Revision

March 19th 2023
© 2023 MJH Life Sciences

All rights reserved.